{
    "Trade/Device Name(s)": [
        "Dario Blood Glucose Monitoring System",
        "Dario Blood Glucose Meter",
        "Dario Glucose Test Strips",
        "Dario Glucose Control Solutions",
        "Dario App"
    ],
    "Submitter Information": "LabStyle Innovation Ltd.",
    "510(k) Number": "K150817",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131230"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "November 20, 2015",
    "Summary Letter Received Date": "November 23, 2015",
    "Submission Date": "December 10, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (Specified) Analyte Controls (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dario Blood Glucose Meter",
        "Smart mobile device (Apple iOS)"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Enzyme-based (Glucose oxidase)"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Application"
    ],
    "Document Summary": "FDA 510(k) summary for Dario Blood Glucose Monitoring System using glucose oxidase-based amperometric technology integrated with a smart mobile device application",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip for self-testing by people with diabetes at home to monitor diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}